Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Atacicpet, Sibeprenlimab Halt Decline in Kidney Function in IgA Nephropathy

(MedPage Today) -- DENVER -- Two IgA nephropathy drugs -- atacicept (Trutakna) and sibeprenlimab injection (Voyxact) -- showed they were able to slow kidney function decline in final phase III trial efficacy analyses. Atacicept and sibeprenlimab...

Atacicpet, Sibeprenlimab Halt Decline in Kidney Function in IgA Nephropathy

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Saturday 24 October →